Syra Health (Syra Health) ROCE % : -186.08% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Syra Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Syra Health's annualized ROCE % for the quarter that ended in Dec. 2023 was -186.08%.

Syra Health ROCE % Historical Data

The historical data trend for Syra Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health ROCE % Chart

Syra Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

-7.41

-486.61

-120.53

Syra Health Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial				-310.59	-311.63	-350.00	-337.89	-186.08

Syra Health ROCE % Calculation

Syra Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-2.885	/	( ( (2.32 - 1.546)	+	(4.923 - 0.91) )	/ 2 )
	=	-2.885	/	( (0.774	+	4.013)	/ 2 )
	=	-2.885	/	2.3935
	=	-120.53 %

Syra Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-3.944	/	( ( (2.607 - 2.381)	+	(4.923 - 0.91) )	/ 2 )
	=	-3.944	/	( ( 0.226	+	4.013 )	/ 2 )
	=	-3.944	/	2.1195
	=	-186.08 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Syra Health (NAS:SYRA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Syra Health ROCE % Related Terms

Thank you for viewing the detailed overview of Syra Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Syra Health (Syra Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032

Website

https://www.syrahealth.com

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.

Executives

Sandeep Allam	director, officer: President and Chair	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed	10 percent owner	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi	director, officer: Chief Executive Officer	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas	10 percent owner	2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc	10 percent owner	6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad	officer: CFO and COO	1119 KEYSTONE WAY N., #201, CARMEL IN 46032